Boothbay Fund Management’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-183,454
| Closed | -$47.5K | – | 1322 |
|
|
2025
Q1 | $47.5K | Hold |
183,454
| – | – | ﹤0.01% | 1116 |
|
|
2024
Q4 | $103K | Sell |
183,454
-39
| -0% | -$22 | ﹤0.01% | 1126 |
|
|
2024
Q3 | $110K | Hold |
183,493
| – | – | ﹤0.01% | 1257 |
|
|
2024
Q2 | $495K | Buy |
183,493
+144,117
| +366% | +$389K | 0.01% | 868 |
|
|
2024
Q1 | $202K | Sell |
39,376
-217,339
| -85% | -$1.11M | ﹤0.01% | 1164 |
|
|
2023
Q4 | $138K | Hold |
256,715
| – | – | ﹤0.01% | 1228 |
|
|
2023
Q3 | $170K | Buy |
256,715
+22,449
| +10% | +$14.9K | ﹤0.01% | 1268 |
|
|
2023
Q2 | $356K | Buy |
+234,266
| New | +$356K | 0.01% | 1045 |
|